ロード中...
Response to inhaled loxapine in patients with schizophrenia or bipolar I disorder: PANSS-EC responder analyses
BACKGROUND: Efficacy of inhaled loxapine 5 or 10 mg in treating agitation was shown using the Positive and Negative Syndrome Scale – Excited Component (PANSS-EC) in two Phase III randomised, double-blind, placebo-controlled trials in 344 agitated patients with schizophrenia and 314 patients with bip...
保存先:
| 出版年: | BJPsych Open |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Royal College of Psychiatrists
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5680528/ https://ncbi.nlm.nih.gov/pubmed/29163985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1192/bjpo.bp.117.005363 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|